| Report ID |
136050 |
| Drug Identification Number |
02237820 |
| Brand name |
AMERGE |
| Common or Proper name |
naratriptan hydrochloride tablets |
| Company Name |
GLAXOSMITHKLINE INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
NARATRIPTAN |
| Strength(s) |
1MG |
| Dosage form(s) |
TABLET |
| Route of administration |
ORAL
ORAL |
| Packaging size |
2's |
| ATC code |
N02CC |
| ATC description |
ANTIMIGRAINE PREPARATIONS |
| Reason for shortage |
Disruption of the manufacture of the drug. |
| Anticipated start date |
|
| Actual start date |
2021-04-08 |
| Estimated end date |
2021-04-26 |
| Actual end date |
2021-04-16 |
| Shortage status |
Resolved |
| Updated date |
2021-04-17 |
| Company comments |
|
| Health Canada comments |
|
| Company contact information |
1-800-387-7374 |
